Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Parallax Health Sciences, Inc. (PRLX)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Parallax Health Sciences, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Parallax Health Sciences, Inc. since 2005.
The reporting company's ticker symbol is PRLX. The reporting company's CIK number is 1388410.
The total value of stock buying since 2005 is $386,500.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-09-30||Bradley Nathaniel T (Chief Technology Officer)||Buy||1,600,000||.06||100,800|
|2019-09-30||Bucci Calli (CFO, Secretary)||Buy||1,600,000||.06||100,800|
|2019-09-30||Ogden John L (Director)||Buy||1,200,000||.06||75,600|
|2019-09-30||Arena Paul R (CEO, President)||Buy||1,600,000||.06||100,800|
|2018-04-06||Arena Paul R (PRESIDENT)||Buy||2,500,000||.00||2,500|
|2018-04-05||Bucci Calli (CFO)||Buy||5,000,000||.00||5,000|
|2018-04-05||Withrow Edward W. Jr (Director)||Buy||500,000||.00||500|
|2018-04-05||Ogden John L (Director)||Buy||500,000||.00||500|
|2014-01-07||Withrow Edward W Iii (Director)||Buy||36,462,819||.00||0|
Insider trading activities including stock purchases, stock sales, and option exercises of PRLX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Parallax Health Sciences, Inc. (symbol PRLX, CIK number 1388410) see the Securities and Exchange Commission (SEC) website.